{"id":6440,"date":"2002-05-11T12:43:41","date_gmt":"2002-05-11T11:43:41","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=6440"},"modified":"2014-06-05T12:06:25","modified_gmt":"2014-06-05T12:06:25","slug":"management-of-co-infection-with-hiv-and-tb","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/6440","title":{"rendered":"Management of co-infection with HIV and TB"},"content":{"rendered":"<p><strong>BMJ 2002;324:802-803<\/strong><\/p>\n<p><strong>Improving tuberculosis control programmes and access to highly active antiretroviral treatment is crucial.<\/strong><\/p>\n<p>About a third of the 36 million people living with HIV worldwide are co-infected with mycobacterium tuberculosis; 70% of those co-infected live in sub-Saharan Africa. In developing countries half of people with HIV infection will develop active tuberculosis; in some countries in sub-Saharan Africa more than 70% of patients with active tuberculosis are also HIV seropositive.<\/p>\n<p>Tuberculosis is the leading cause of death among people with HIV infection, accounting for a third of deaths due to AIDS world wide. The introduction of highly active antiretroviral therapy has decreased death and opportunistic infections by 60% to 90% among people living with HIV in affluent countries.<\/p>\n<p>But in developing countries highly active antiretroviral therapy is available to a tiny minority of those who need it. Today there is a shocking inequality worldwide in the prognosis of HIV and tuberculosis co-infection, and it depends on whether patients or their country have access to highly active antiretroviral therapy.<\/p>\n<p>Full text at<br \/>\n<a href=\"http:\/\/bmj.com\/cgi\/content\/full\/324\/7341\/802\">http:\/\/bmj.com\/cgi\/content\/full\/324\/7341\/802<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BMJ 2002;324:802-803 Improving tuberculosis control programmes and access to highly active antiretroviral treatment is crucial. About a third of the 36 million people living with HIV worldwide are co-infected with mycobacterium tuberculosis; 70% of those co-infected live in sub-Saharan Africa. &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-6440","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=6440"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6440\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=6440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=6440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=6440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}